Testing effectiveness (Phase 2)Ended earlyNCT01518153
What this trial is testing
Planned Donor Lymphocyte Infusion (DLI) After Allogeneic Stem Cell Transplantation (SCT)
Who this might be right for
LeukemiaLymphomaMyeloma+1 more
M.D. Anderson Cancer Center 16